focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.50
Bid: 1,812.50
Ask: 1,813.00
Change: 2.50 (0.14%)
Spread: 0.50 (0.028%)
Open: 1,811.00
High: 1,820.00
Low: 1,803.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Berenberg - Buy Dignity; Liberum - Buy Genus

Fri, 01st Jul 2016 08:51

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
JPMORGAN RAISES SMITH & NEPHEW PRICE TARGET TO 1196 (1096) PENCE - 'NEUTRAL'
----------
Investec Ups Diageo Target To 2,300p From 2,160p, Keeps Buy
----------
CITIGROUP RAISES GLAXOSMITHKLINE PRICE TARGET TO 1800 (1550) PENCE - 'BUY'
----------
CREDIT SUISSE RAISES ROLLS ROYCE PRICE TARGET TO 590 (534.3) PENCE - 'UNDERP.'
----------
CREDIT SUISSE CUTS ITV PRICE TARGET TO 200 (255) PENCE - 'OUTPERFORM'
----------
HSBC CUTS ITV PRICE TARGET TO 200 (280) PENCE - 'BUY'
----------
BERENBERG CUTS SKY PRICE TARGET TO 730 (784) PENCE - 'SELL'
----------
GOLDMAN RAISES MONDI PRICE TARGET TO 1325 (1250) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS JOHNSON MATTHEY PRICE TARGET TO 3250 (3865) PENCE - 'BUY'
----------
UBS RAISES OLD MUTUAL PRICE TARGET TO 210 (200) PENCE - 'BUY'
----------
UBS CUTS AVIVA PRICE TARGET TO 400 (455) PENCE - 'NEUTRAL'
----------
UBS CUTS DIRECT LINE PRICE TARGET TO 352 (390) PENCE - 'NEUTRAL'
----------
UBS RAISES CARNIVAL PLC PRICE TARGET TO 4050 (3850) PENCE - 'BUY'
----------
FTSE 250
----------
JPMORGAN CUTS JOHN WOOD GROUP PRICE TARGET TO 570 (600) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS HOWDEN JOINERY TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 390 (570) PENCE
----------
JPMORGAN CUTS GREENE KING PRICE TARGET TO 950 (1050) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES SERCO GROUP PRICE TARGET TO 133 (130) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS GO-AHEAD GROUP PRICE TARGET TO 2390 (2427) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES NATIONAL EXPRESS PRICE TARGET TO 397 (362) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES FIRSTGROUP PRICE TARGET TO 145 (141) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS STAGECOACH GROUP TO 'UNDERWEIGHT' ('NEUTRAL'), PRICE TARGET 180 (256) PENCE
----------
JPMORGAN RAISES DAIRY CREST GROUP TO 'OVERWEIGHT' ('NEUTRAL')
----------
CITIGROUP RAISES SAFESTORE PRICE TARGET TO 440 (400) PENCE - 'BUY'
----------
PANMURE INITIATES TULLOW OIL PLC WITH 'SELL' - TARGET 210 PENCE
----------
CREDIT SUISSE RAISES TULLOW OIL PRICE TARGET TO 370 (330) PENCE - 'OUTPERFORM'
----------
Cantor Cuts Tullow Oil To Sell From Hold, Keeps Target At 163p
----------
CANACCORD CUTS MARSHALLS GROUP TO 'HOLD' ('BUY')
----------
Liberum Ups Tate & Lyle Target To 790p From 730p, Keeps Buy
----------
Liberum Ups Genus To Buy From Hold, Target To 1,750p From 1,500p
----------
GOLDMAN CUTS DS SMITH PRICE TARGET TO 390 (395) PENCE - 'NEUTRAL'
----------
TRADERS: MERRILL LYNCH RAISES ABERDEEN ASSET MANAGEMENT TO 'BUY' ('UNDERPERFORM')
----------
BERENBERG CUTS DOMINO'S PIZZA PRICE TARGET TO 400 (1200) PENCE - 'BUY'
----------
BERENBERG RAISES DIGNITY TO 'BUY' ('HOLD') - TARGET 2825 (2400) PENCE
----------
TRADERS: MACQUARIE INITIATES RIGHTMOVE WITH 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
JPMORGAN CUTS MOTHERCARE PRICE TARGET TO 180 (201) PENCE - 'OVERWEIGHT'
----------
Investec Ups Wynnstay Group To Hold From Sell, Cuts Target to 422p From 485p
----------
BERENBERG CUTS STAFFLINE TO 'HOLD' ('BUY') - TARGET 900 (1700) PENCE
----------
BERENBERG CUTS INTERSERVE TO 'HOLD' ('BUY') - TARGET 330 (520) PENCE
----------
Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.